Nationwide Fund Advisors’s Progenics Pharmaceuticals Inc PGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | – | Sell |
-38,428
| Closed | -$283K | – | 2677 |
|
|
2017
Q3 | $283K | Sell |
38,428
-1,807
| -4% | -$13.3K | ﹤0.01% | 2467 |
|
|
2017
Q2 | $273K | Sell |
40,235
-1,578
| -4% | -$10.7K | ﹤0.01% | 2492 |
|
|
2017
Q1 | $395K | Sell |
41,813
-692
| -2% | -$6.54K | ﹤0.01% | 2273 |
|
|
2016
Q4 | $367K | Sell |
42,505
-1,699
| -4% | -$14.7K | ﹤0.01% | 2339 |
|
|
2016
Q3 | $280K | Hold |
44,204
| – | – | ﹤0.01% | 2461 |
|
|
2016
Q2 | $187K | Hold |
44,204
| – | – | ﹤0.01% | 2649 |
|
|
2016
Q1 | $193K | Sell |
44,204
-2,179
| -5% | -$9.51K | ﹤0.01% | 2550 |
|
|
2015
Q4 | $284K | Buy |
46,383
+1,063
| +2% | +$6.51K | ﹤0.01% | 2380 |
|
|
2015
Q3 | $259K | Hold |
45,320
| – | – | ﹤0.01% | 2439 |
|
|
2015
Q2 | $338K | Sell |
45,320
-5,569
| -11% | -$41.5K | ﹤0.01% | 2455 |
|
|
2015
Q1 | $304K | Sell |
50,889
-2,650
| -5% | -$15.8K | ﹤0.01% | 2488 |
|
|
2014
Q4 | $405K | Sell |
53,539
-775
| -1% | -$5.86K | ﹤0.01% | 2304 |
|
|
2014
Q3 | $282K | Buy |
54,314
+130
| +0.2% | +$675 | ﹤0.01% | 2532 |
|
|
2014
Q2 | $234K | Buy |
54,184
+1,722
| +3% | +$7.44K | ﹤0.01% | 2673 |
|
|
2014
Q1 | $215K | Buy |
52,462
+6,201
| +13% | +$25.4K | ﹤0.01% | 2460 |
|
|
2013
Q4 | $247K | Sell |
46,261
-26,033
| -36% | -$139K | ﹤0.01% | 2590 |
|
|
2013
Q3 | $364K | Buy |
72,294
+11,076
| +18% | +$55.8K | ﹤0.01% | 2378 |
|
|
2013
Q2 | $273K | Buy |
+61,218
| New | +$273K | ﹤0.01% | 2344 |
|